» Articles » PMID: 3857233

Clostridium Difficile in Haematological Malignancy

Overview
Journal J Clin Pathol
Specialty Pathology
Date 1985 Apr 1
PMID 3857233
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Twenty patients with haematological malignancies who developed Clostridium difficile bowel infection or colonisation are described. All isolates of C difficile were toxigenic in vitro and faecal cytotoxin (toxin B) was detected in 20/26 episodes. Ten of 20 episodes with detectable faecal cytotoxin were associated with typical antibiotic associated diarrhoea. In the other 10 episodes (nine patients), there was a severe unusual illness which was associated with detection of C difficile. The unusual features of the illness were pronounced jaundice (total bilirubin greater than or equal to 44 mumol/l), abdominal pain and distension, and initial constipation followed either by diarrhoea or by large bowel stasis. Four of these patients died within seven days. Bacteraemia was often a presenting feature in neutropenic patients subsequently shown to have C difficile. This was not the case in non-neutropenic patients. Bacteraemia was commonly polymicrobial and in two cases C difficile was isolated from blood culture. The clinical implications of recognition of this atypical C difficile associated syndrome are discussed.

Citing Articles

Recognition, Diagnosis, and Treatment of Enterocolitis Presenting Without Diarrhea: A Literature Review.

Yilmaz E, Gencer D, Akin M, Sahin M, Ceylan B, Mert A Pathogens. 2025; 14(2).

PMID: 40005556 PMC: 11858188. DOI: 10.3390/pathogens14020181.


Targeting Surface Components to Develop Immunotherapeutic Strategies Against Infection.

Pechine S, Bruxelle J, Janoir C, Collignon A Front Microbiol. 2018; 9:1009.

PMID: 29875742 PMC: 5974105. DOI: 10.3389/fmicb.2018.01009.


bacteremia: Report of two cases in French hospitals and comprehensive review of the literature.

Doufair M, Eckert C, Drieux L, Amani-Moibeni C, Bodin L, Denis M IDCases. 2017; 8:54-62.

PMID: 28417069 PMC: 5390667. DOI: 10.1016/j.idcr.2017.03.012.


Clostridium difficile Infections amongst Patients with Haematological Malignancies: A Data Linkage Study.

Selvey L, Slimings C, Joske D, Riley T PLoS One. 2016; 11(6):e0157839.

PMID: 27314498 PMC: 4912117. DOI: 10.1371/journal.pone.0157839.


Predictors of mortality attributable to Clostridium difficile infection in patients with underlying malignancy.

Yoon Y, Kim M, Sohn J, Kim H, Choi Y, Kim J Support Care Cancer. 2014; 22(8):2039-48.

PMID: 24595407 DOI: 10.1007/s00520-014-2174-7.


References
1.
Enno A, Catovsky D, Darrell J, Goldman J, Hows J, GALTON D . Co-trimoxazole for prevention of infection in acute leukaemia. Lancet. 1978; 2(8086):395-7. DOI: 10.1016/s0140-6736(78)91865-2. View

2.
Dosik G, Luna M, Valdivieso M, McCredie K, Gehan E, Gil-Extremera B . Necrotizing colitis in patients with cancer. Am J Med. 1979; 67(4):646-56. DOI: 10.1016/0002-9343(79)90248-1. View

3.
Milligan D, Kelly J . Pseudomembranous colitis in a leukaemia unit: a report of five fatal cases. J Clin Pathol. 1979; 32(12):1237-43. PMC: 1145943. DOI: 10.1136/jcp.32.12.1237. View

4.
Rifkin G . Neutropenic enterocolitis and Clostridium septicum infection in patients with agranulocytosis. Arch Intern Med. 1980; 140(6):834-5. View

5.
Bartlett J . Antibiotic-associated pseudomembranous colitis. Rev Infect Dis. 1979; 1(3):530-9. DOI: 10.1093/clinids/1.3.530. View